Basel Medical (BMGL) Cash & Equivalents (2023 - 2025)

Basel Medical's Cash & Equivalents history runs 3 years deep, the most recent figure standing at $2.3 million for Q2 2025.

• In Q2 2025, Cash & Equivalents rose 62.19% year-over-year to $2.3 million; the TTM figure through Jun 2025 stood at $2.3 million (up 62.19% YoY), while the FY2025 annual figure was $2.4 million, up 65.99% from the prior year.
• Cash & Equivalents came in at $2.3 million for Q2 2025 at Basel Medical, up from $1.4 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $2.3 million in Q2 2025 to a low of $901754.6 in Q4 2023.
• A 3-year average of $1.5 million and a median of $1.4 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents surged 58.37% in 2024 and jumped 62.19% in 2025, its largest moves.
• Basel Medical's Cash & Equivalents stood at $901754.6 in 2023, then soared by 58.37% to $1.4 million in 2024, then jumped by 63.78% to $2.3 million in 2025.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $2.3 million, $1.4 million, and $1.4 million for Q2 2025, Q4 2024, and Q2 2024 respectively.

Peer Comparison